Definitive Healthcare Corp. (DH) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Definitive Healthcare Corp. (DH) Healthcare & Pipeline Overview

Definitive Healthcare Corp. delivers commercial intelligence to the healthcare sector in the United States, equipping clients with data-driven insights for product development, marketing strategies, and sales execution. Its comprehensive platform, featuring 16 intelligence modules, caters to biopharmaceutical, medical device, and healthcare IT companies.

What Is the Investment Thesis for DH?

Definitive Healthcare Corp. operates in the growing healthcare commercial intelligence market. The company's platform, with its 16 intelligence modules, offers a comprehensive solution for clients across the healthcare spectrum. However, the company's negative profit margin of -57.5% raises concerns about its profitability. Growth catalysts include expanding its customer base and enhancing its product offerings. The company's high beta of 1.60 suggests higher volatility compared to the broader market. Investors should carefully consider the company's financial performance and market dynamics before making investment decisions. Key value drivers include increasing subscription revenue and expanding into new market segments.

Based on FMP financials and quantitative analysis

DH Key Highlights

Definitive Healthcare Corp. operates in the healthcare commercial intelligence sector, providing data and analytics solutions.

• The company's platform offers 16 intelligence modules covering areas like sales, marketing, and product development.
• Definitive Healthcare serves a diverse range of customers, including biopharmaceutical, medical device, and healthcare IT companies.
• The company's gross margin stands at 75.9%, indicating strong pricing power and efficient cost management.
• Definitive Healthcare Corp. has a market capitalization of $109M, reflecting its current market valuation.

Who Are DH's Competitors?

DH is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are DH's Key Strengths?

Comprehensive healthcare commercial intelligence platform.

• Diverse customer base across the healthcare ecosystem.
• Established presence in the United States.
• Strong gross margin of 75.9%.

What Are DH's Weaknesses?

Negative profit margin of -57.5%.

• High beta of 1.60, indicating higher volatility.
• Reliance on the U.S. market.
• Limited brand recognition outside the healthcare sector.

What Could Drive DH Stock Higher?

Expansion of product offerings with new intelligence modules.

• Strategic partnerships and acquisitions to expand capabilities and market reach.
• Penetration of new customer segments within the healthcare ecosystem.

What Are the Key Risks for DH?

Financial-distress signal — its Altman Z-Score of -3.16 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-67.1%) — the business is not currently generating profit on shareholder capital.
• Increasing competition in the healthcare information services industry.
• Changes in healthcare regulations and policies.
• Economic downturn affecting healthcare spending.
• Data security and privacy concerns.

What Are the Growth Opportunities for DH?

• Expansion into New Geographic Markets: Definitive Healthcare has the opportunity to expand its presence beyond the United States and enter new geographic markets. The global healthcare analytics market is estimated to reach $75 billion by 2027, presenting significant growth potential for the company. By establishing a presence in key international markets, Definitive Healthcare can diversify its revenue streams and capitalize on the growing demand for healthcare commercial intelligence worldwide. This expansion could involve strategic partnerships, acquisitions, or organic growth initiatives, with a timeline of 3-5 years.
• Enhancement of Product Offerings: Definitive Healthcare can further enhance its product offerings by developing new intelligence modules and integrating advanced analytics capabilities into its platform. This could involve incorporating artificial intelligence and machine learning technologies to provide more predictive and personalized insights to its clients. By continuously innovating and expanding its product portfolio, Definitive Healthcare can strengthen its competitive position and attract new customers. The timeline for these enhancements is estimated at 2-3 years.
• Strategic Partnerships and Acquisitions: Definitive Healthcare can pursue strategic partnerships and acquisitions to expand its capabilities and market reach. This could involve partnering with complementary technology providers or acquiring companies with specialized expertise in areas such as healthcare data analytics or market research. By leveraging the strengths of its partners and acquired companies, Definitive Healthcare can accelerate its growth and enhance its value proposition. The timeline for these partnerships and acquisitions is ongoing.
• Penetration of New Customer Segments: Definitive Healthcare can target new customer segments within the healthcare ecosystem, such as pharmaceutical companies, insurance providers, and government agencies. These segments represent significant growth opportunities for the company, as they increasingly rely on data-driven insights to make informed decisions. By tailoring its solutions to meet the specific needs of these customer segments, Definitive Healthcare can expand its customer base and increase its revenue. The timeline for this penetration is estimated at 3-5 years.
• Leveraging Data Monetization Opportunities: Definitive Healthcare can explore opportunities to monetize its extensive healthcare data assets by offering customized data products and services to its clients. This could involve providing access to anonymized patient data for research purposes or developing specialized data reports and dashboards for specific industry segments. By leveraging its data assets, Definitive Healthcare can generate new revenue streams and enhance its profitability. The timeline for these monetization opportunities is estimated at 2-3 years.

What Are DH's Competitive Advantages?

• Proprietary data assets and analytics platform.
• Comprehensive suite of 16 intelligence modules.
• Established relationships with key players in the healthcare ecosystem.

What Does DH Do?

Founded in 2011 and headquartered in Framingham, Massachusetts, Definitive Healthcare Corp. has emerged as a key player in the healthcare commercial intelligence sector. The company provides data and analytics solutions to healthcare providers and organizations across the United States. Its platform offers a suite of 16 intelligence modules designed to support various functional areas, including sales, marketing, clinical research, product development, strategy, talent acquisition, and physician network management. These modules provide detailed information on healthcare providers and their activities, enabling clients to make informed decisions across their operations. Definitive Healthcare's solutions assist clients in areas ranging from identifying market opportunities and developing new products to optimizing go-to-market strategies and enhancing sales and marketing effectiveness. The company serves a diverse range of customers, including biopharmaceutical and medical device companies, healthcare information technology companies, healthcare providers, and other organizations within the healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other diversified entities.

What Products and Services Does DH Offer?

• Provides healthcare commercial intelligence in the United States.
• Offers a platform with 16 intelligence modules covering various functional areas.
• Serves biopharmaceutical and medical device companies.
• Supports healthcare information technology companies.
• Caters to healthcare providers.
• Assists staffing and commercial real estate companies in the healthcare ecosystem.
• Provides data to financial institutions.

How Does DH Make Money?

• Subscription-based access to its healthcare commercial intelligence platform.
• Provides data and analytics solutions to healthcare providers and organizations.
• Offers customized data products and services to clients.

What Industry Does DH Operate In?

Definitive Healthcare Corp. operates within the healthcare information services industry, a sector experiencing growth due to the increasing demand for data-driven insights in healthcare decision-making. The market is competitive, with companies offering various solutions for healthcare data analytics and commercial intelligence. Definitive Healthcare differentiates itself through its comprehensive platform and focus on providing actionable insights to its clients. The healthcare analytics market is projected to continue growing, driven by factors such as the increasing adoption of electronic health records, the rise of value-based care, and the growing need for healthcare organizations to improve operational efficiency and patient outcomes.

Who Are DH's Key Customers?

• Biopharmaceutical companies
• Medical device companies
• Healthcare information technology companies
• Healthcare providers
• Staffing and commercial real estate companies

Company Profile

Definitive Healthcare Corp. operates in the Medical - Healthcare Information Services industry within the Healthcare sector. It is headquartered in Framingham, US. The company is led by CEO Kevin D. Coop. DH has traded publicly since 2021.

Return on equity for Definitive Healthcare Corp. stands at -67.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -33.1%, showing how much profit it generates from its asset base. Its free cash flow yield is 46.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.66 indicates the company holds enough short-term assets to cover its near-term obligations.

DH Valuation & Market Position

With a $109M market cap, Definitive Healthcare Corp. sits in the micro-cap segment of the market. Analyst price targets span from $1.00 to $1.50, with a consensus of $1.20. At the current price of $1.03, that implies approximately 17% upside potential. Relative to its peer group, DH's quantitative score of 22/100 is below the peer average of 76/100.

Quarterly Financial Performance: Definitive Healthcare Corp.

Revenue for Definitive Healthcare Corp. came in at $55.2M during Q2 FY2026, a 1.3% contraction versus the preceding quarter. The company recorded a net loss of $5.4M, with diluted EPS of $-0.05. Revenue has contracted over three consecutive quarters, which investors in this micro-cap Healthcare stock should monitor closely. Across the four most recent quarters, DH averaged $-0.40 in diluted EPS.

Definitive Healthcare Corp.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -3.16 places it in the distress zone, a signal of elevated financial risk.

Definitive Healthcare Corp. has beaten Wall Street's EPS estimate in 7 of its last 8 reported quarters — a consistent record of delivering on expectations. Reported results have landed about 45.4% above estimates on average.

Over the past six months, Definitive Healthcare Corp. insiders filed 13 SEC Form 4 transactions — 9 sales and 4 purchases. On net that is roughly 537K shares acquired (about $205K) — insiders putting money in tends to read as conviction.

DH Financials

DH Latest News

DH Analyst Consensus

DH MoonshotScore

Common Questions About DH (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources